These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab. Ojogho O; Sahney S; Cutler D; Baron PW; Abdelhalim FM; James S; Zuppan C; Franco E; Concepcion W Pediatr Transplant; 2005 Feb; 9(1):80-3. PubMed ID: 15667617 [TBL] [Abstract][Full Text] [Related]
8. Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients. Kovac D; Kotnik V; Kandus A Transplant Proc; 2005 Dec; 37(10):4230-4. PubMed ID: 16387086 [TBL] [Abstract][Full Text] [Related]
9. Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal transplantation: a prospective, randomized study. Kandus A; Arnol M; Omahen K; Oblak M; Vidan-Jeras B; Kmetec A; Bren AF Transplantation; 2010 Apr; 89(8):1022-7. PubMed ID: 20075788 [TBL] [Abstract][Full Text] [Related]
10. A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function. Andrés A; Marcén R; Valdés F; Plumed JS; Solà R; Errasti P; Lauzurica R; Pallardó L; Bustamante J; Amenábar JJ; Plaza JJ; Gómez E; Grinyó JM; Rengel M; Puig JM; Sanz A; Asensio C; Andrés I; Clin Transplant; 2009; 23(1):23-32. PubMed ID: 18798851 [TBL] [Abstract][Full Text] [Related]
11. Basiliximab (Simulect) in renal transplantation with high risk for delayed graft function. Fernandez Rivera C; Alonso Hernandez A; Villaverde Verdejo P; Oliver García J; Valdés Cañedo F Transplant Proc; 2005 Apr; 37(3):1435-7. PubMed ID: 15866629 [TBL] [Abstract][Full Text] [Related]
12. Recovery of graft function in pediatric kidney transplantation is not affected by delayed introduction of cyclosporine. Cransberg K; Bouts AH; Cornelissen EA; Lilien MR; Van Hoeck KJ; Hop WC; Nauta J Transplantation; 2008 Nov; 86(9):1199-205. PubMed ID: 19005400 [TBL] [Abstract][Full Text] [Related]
13. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen. Yang SL; Wang D; Wu WZ; Lin WH; Xu TZ; Cai JQ; Tan JM Transpl Immunol; 2008 Jan; 18(3):281-5. PubMed ID: 18047938 [TBL] [Abstract][Full Text] [Related]
14. Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal graft recipients. Grego K; Arnol M; Bren AF; Kmetec A; Tomaziĉ J; Kandus A Transplant Proc; 2007 Dec; 39(10):3093-7. PubMed ID: 18089329 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporine-sparing effect of basiliximab in renal transplant recipients with mycophenolate mofetil. Tojimbara T; Sato S; Koyama I; Nanmoku K; Sekijima M; Tonsyo M; Kai K; Kato Y; Urashima Y; Nakajima I; Fuchinoue S; Teraoka S Transplant Proc; 2005 Mar; 37(2):895-8. PubMed ID: 15848568 [TBL] [Abstract][Full Text] [Related]
16. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation. Clark G; Walsh G; Deshpande P; Koffman G Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256 [TBL] [Abstract][Full Text] [Related]
17. A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin. Wang W; Yin H; Li XB; Hu XP; Yang XY; Liu H; Ren L; Wang Y; Zhang XD Chin Med J (Engl); 2012 Mar; 125(6):1135-40. PubMed ID: 22613543 [TBL] [Abstract][Full Text] [Related]
18. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960 [TBL] [Abstract][Full Text] [Related]
19. Comparison of basiliximab and daclizumab with triple immunosuppression in renal transplantation. Aktas S; Colak T; Baskin E; Sevmis S; Ozdemir H; Moray G; Karakayali H; Haberal M Transplant Proc; 2011 Mar; 43(2):453-7. PubMed ID: 21440732 [TBL] [Abstract][Full Text] [Related]
20. Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year. Duzova A; Buyan N; Bakkaloglu M; Dalgic A; Soylemezoglu O; Besbas N; Bakkaloglu A Transplant Proc; 2003 Dec; 35(8):2878-80. PubMed ID: 14697926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]